논문KCI 등재
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (2)
- Yee Hui Yeo, "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma", Clinical and Molecular Hepatology, 29(3), pp.721~732 (2023), 대한간학회
- Kleebayoon A, "Artificial intelligence, chatbots, plagiarism and basic honesty : Comment", Cell Mol Bioeng, 16, pp.173~174 (2023)
관련 논문AI추천
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Bin Sheng, Hanyun Liu, Hongwei Ji, Lili Xu, Linlin Ren, Liwei Wu, Susan Cheng, Tien Yin Wong, Yangang Wang, Yaxing Wang, Yih Chung Tham, Ying Chen, Yiwen Zhang, Zepeng Mu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Jamil S. Samaan, Wee Han Ng, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Hinpetch Daungsupawong, Viroj Wiwanitkit대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Hassam Ali대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Jamil S. Samaan, Wee Han Ng, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”Ju Dong Yang, Yee Hui Yeo대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호
이 간행물의 다른 논문 (26건)
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer AssociationHyunchul Rhim, 김경민, Jin Woo Choi, Hee Ho Chu, Jung Suk Oh, In Joon Lee, Dong Hyeon Lee, Byung Chan Lee, Yuri Cho, Han Ah Lee, Dongho Hyun, Hoon Kwon, Kun Yung Kimpp. 521-541KASL clinical practice guidelines for management of autoimmune hepatitis 2022The Korean Association for the Study of the Liver (KASL)pp. 542-592Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversityTakumi Kawaguchi, Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimosepp. 593-604Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infectionChih-Lin Lin, Jia-Horng Kaopp. 605-622Acute hepatitis C virus infection: clinical update and remaining challengesJia-Horng Kao, Chen-Hua Liupp. 623-642